Insights On Pharmaceutical Production

  1. The Pharma Trends You Need To Know: A CDMO’s Perspective

    Companies must understand how today’s new pharmaceutical landscape is causing a dramatic shift in how we plan for and execute drug development and manufacturing.

  2. Quick To Clinic™ for Oral Solid Dose

    In as little as 14 weeks from receiving your small molecule API, you can have your Phase I drug product manufactured, labelled, packaged and delivered to the clinic. That’s 1 month faster than most standard timelines, and includes a one-month stability study.

  3. The Race To Phase III: A Cautionary Tale Of Scalability

    Follow the paths of two companies as they learn how a science-led, risk-based development approach yields a more successful outcome in the long run.

  4. What Dosage Form Provides A Release Drug Control Rate?

    Whether your goal is to increase patient compliance, improve clinical outcomes, or to extend a product’s lifecycle, modified-release dosage forms present a solution to myriad challenges. 

  5. Meeting Regulatory Requirements With A Trusted Equipment Partner

    Pharmaceutical suppliers are tasked with responding to ever-evolving changes in regulatory requirements, which impact everything within an organization—from operations to the way trials are conducted.

  6. Keeping Pace With Increasing Biopharmaceutical Manufacturing Demand

    Today’s biologics pipeline is healthy, but near-term forecasts indicate growth so robust, the industry risks being ill-equipped to meet demand. Can biopharma count on contract manufacturers to rise to the demand challenge?

  7. Recommended Mixing Equipment For Pharmaceutical Gels

    A majority of pharmaceutical gels are shear-thinning semisolids prepared by dispersing hydrophilic polymers into an aqueous vehicle. Proper mixing requires a good balance between agitation and shear.

  8. Bioprocess Plant Cuts Down Time With Self-Calibrating Temperature Sensor

    To keep the risks in bioproduction as low as possible, an increase in calibration frequency is required. Read how the self-calibrating iTHERM TrustSens temperature sensor kept downtime to a minimum.

  9. Using A CMO To Streamline Process Characterization

    While traditional small molecule drug products usually consist of pure chemical substances that are easily analyzed after manufacture, biologics such as monoclonal antibodies (mAbs) are much more complex. 

  10. Selecting A CMO: Top Considerations

    Choosing the right contract organization to handle the development and manufacturing of a drug product is of critical importance. Here are tips to ensure a successful outcome.